Here's What Key Metrics Tell Us About Medtronic (MDT) Q1 Earnings

MDT reported first-quarter revenue of $9.76 billion for the period ended July 2026, beating consensus by 3.02% and marking a 13.7% year-over-year increase. Earnings per share came in at $1.45, topping the $1.39 estimate by 4.32%.

The cardiovascular segment led growth with a 19.5% year-over-year jump, while the diabetes business expanded 16.9%. The company's 'Other' category posted a significant decline, though specific figures were not disclosed.

MDT currently carries a Zacks Rank #3 (Hold) rating following the results. The double beat on both top and bottom lines reflects stronger-than-expected performance across the company's two largest growth drivers, though the weakness in the unspecified 'Other' segment introduces a potential drag.